| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
– SEC Filing
In a communication to employees on March 14, 2024, WW International, Inc. (the "Company") disclosed that it is on track to beat its previously provided first quarter fiscal 2024 guidance for end of period Clinical subscribers.
This guidance reflects management's current expectations about the Company's future performance based on information available at this time and constitutes forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ from those indicated by these forward-looking statements as a result of various important factors, including the risk factors discussed in the Company's Annual Report on Form 10-K filed on February 28, 2024 with the Securities and Exchange Commission.
Posted In: WW
